Price Controls and Drug Affordability in India: Policy Options

Prabodh Malhotra

Chapter 6 in Impact of TRIPS in India, 2010, pp 111-130 from Palgrave Macmillan

Abstract: Abstract Earlier work (Goddard et al. 2006) served to emphasise the significance of drug price controls that are an important policy instrument, because health systems cannot rely entirely on market mechanisms for healthcare delivery. Price controls are a method of regulating drug prices for achieving health policy goals (Gray & Matsebula 2003). The governments use interventions from the supply side by controlling drug prices and/or from the demand side by restricting reimbursements and by raising patient co-payments (Cai & Salmon 2005). From the manufacturers’ perspective, price controls restrict free market activity, limit profits, and restrict return on investment.

Keywords: Reference Price; Drug Price; Transfer Price; Price Control; Essential Drug (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-29074-7_6

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230290747

DOI: 10.1057/9780230290747_6

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().